These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2294144)
1. Absence of natural killer (NK) cell activity against oligodendrocytes in multiple sclerosis. Satoh J; Kim SU; Kastrukoff LF J Neuroimmunol; 1990 Jan; 26(1):75-80. PubMed ID: 2294144 [TBL] [Abstract][Full Text] [Related]
2. Cytolysis of oligodendrocytes is mediated by killer (K) cells but not by natural killer (NK) cells. Satoh J; Kim SU; Kastrukoff LF J Neuroimmunol; 1991 Mar; 31(3):199-210. PubMed ID: 1995651 [TBL] [Abstract][Full Text] [Related]
3. Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: assessment by 51Cr release assay. Suzumura A; Lisak RP; Silberberg DH J Neuroimmunol; 1986 Apr; 11(2):137-47. PubMed ID: 3949965 [TBL] [Abstract][Full Text] [Related]
4. Lymphokine-activated killer (LAK) and adherent LAK (A-LAK) activity in multiple sclerosis. Satoh J; Kim SU; Kastrukoff LF J Neuroimmunol; 1991 May; 32(2):111-22. PubMed ID: 2013616 [TBL] [Abstract][Full Text] [Related]
5. KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects. Banerjee PP; Pang L; Soldan SS; Miah SM; Eisenberg A; Maru S; Waldman A; Smith EA; Rosenberg-Hasson Y; Hirschberg D; Smith A; Ablashi DV; Campbell KS; Orange JS Mol Immunol; 2019 Nov; 115():39-55. PubMed ID: 30482463 [TBL] [Abstract][Full Text] [Related]
6. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D. Uchida A; Klein E Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity of peripheral blood and cerebrospinal fluid lymphocytes from patients with multiple sclerosis and other neurological diseases. Analysis at the single cell level using morphological and surface marker phenotype criteria. Merrill JE; Scott A; Myers L; Ellison G J Neuroimmunol; 1982 Oct; 3(2):123-38. PubMed ID: 6981657 [TBL] [Abstract][Full Text] [Related]
9. Regulation of natural killer cell cytotoxicity by prostaglandin E in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis and other neurological diseases. Part 2. Effect of exogenous PGE1 on spontaneous and interferon-induced natural killer. Merrill JE; Myers LW; Ellison GW J Neuroimmunol; 1983 Jun; 4(3):239-51. PubMed ID: 6189856 [TBL] [Abstract][Full Text] [Related]
10. Natural killer cell number and activity in multiple sclerosis. Vranes Z; Poljaković Z; Marusić M J Neurol Sci; 1989 Dec; 94(1-3):115-23. PubMed ID: 2614463 [TBL] [Abstract][Full Text] [Related]
11. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus. Sibbitt WL; Mathews PM; Bankhurst AD Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394 [TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of natural killer cytotoxicity. II. coculture of human PBL with NK-sensitive or resistant cell lines stimulates release of natural killer cytotoxic factors (NKCF) selectively cytotoxic to NK-sensitive target cells. Wright SC; Weitzen ML; Kahle R; Granger GA; Bonavida B J Immunol; 1983 May; 130(5):2479-83. PubMed ID: 6833762 [TBL] [Abstract][Full Text] [Related]
13. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Neighbour PA; Grayzel AI; Miller AE Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920 [TBL] [Abstract][Full Text] [Related]
14. Strong natural killer (NK) cell activity in bone marrow of myeloma patients: accelerated maturation of bone marrow NK cells and their interaction with other bone marrow cells. Uchida A; Yagita M; Sugiyama H; Hoshino T; Moore M Int J Cancer; 1984 Sep; 34(3):375-81. PubMed ID: 6592156 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of cell-mediated cytotoxicity at the single-cell level. VII. Trigger of the lethal hit event is distinct for NK/K and LDCC effector cells as measured in the two-target conjugate assay. Bradley TP; Bonavida B Cell Immunol; 1984 Jan; 83(1):199-207. PubMed ID: 6420079 [TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis: rat and human oligodendrocytes are not the target for CSF immunoglobulins. Lubetzki C; Lombrail P; Hauw JJ; Zalc B Neurology; 1986 Apr; 36(4):524-8. PubMed ID: 3960327 [TBL] [Abstract][Full Text] [Related]
18. [The natural cytotoxicity system in patients with multiple sclerosis: clinico-immunological parallels]. Cheknev SB; Latysheva OL; Demina TL; Sorokin AM; Gusev EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):16-9. PubMed ID: 2800805 [TBL] [Abstract][Full Text] [Related]
19. Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon. Kastrukoff LF; Morgan NG; Aziz TM; Zecchini D; Berkowitz J; Paty DW J Neuroimmunol; 1988 Nov; 20(1):15-23. PubMed ID: 3183034 [TBL] [Abstract][Full Text] [Related]
20. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility. Uchida A; Vánky F; Klein E J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]